» Articles » PMID: 28676973

Chronic Consumption of Fructose in Combination with Trans Fatty Acids but Not with Saturated Fatty Acids Induces Nonalcoholic Steatohepatitis with Fibrosis in Rats

Overview
Journal Eur J Nutr
Date 2017 Jul 6
PMID 28676973
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Consumption of Western diet high in fat and fructose has been attributed to the recent epidemic of nonalcoholic fatty liver disease (NAFLD). However, the impact of specific fatty acids on the progression of NAFLD to nonalcoholic steatohepatitis (NASH) is poorly understood. In the present study, we investigated the chronic effects of consumption of fructose in combination with saturated fatty acids (SFA) or trans fatty acids (TFA) on the development of NAFLD.

Methods: Male Sprague-Dawley rats were randomly assigned to six isocaloric starch/high fructose (44% of calories), high fat (39% calories) diet containing either starch-peanut oil, fructose-peanut oil, fructose-palmolein, fructose-clarified butter, fructose-coconut oil or fructose-partially hydrogenated vegetable oil and fed for 24 weeks. Palmolein, clarified butter and coconut oil were used as the source of SFA whereas partially hydrogenated vegetable oil was used as the source of TFA. Peanut oil was used as the reference oil.

Results: Long-term feeding of fructose in combination with SFA or TFA induced hepatic steatosis of similar extent associated with upregulation of stearoyl CoA desaturase-1. In contrast, fructose in combination with TFA induced NASH with fibrosis as evidenced by upregulation of hepatic proinflammatory cytokine and fibrogenic gene expression, increased hepatic oxidative stress and adipocytokine imbalance. Histopathological analysis revealed the presence of NASH with fibrosis. Further, peanut oil prevented the development of NAFLD in fructose-fed rats.

Conclusion: Fructose in combination with TFA caused NASH with fibrosis by inducing oxidative stress and inflammation, whereas, fructose in combination with SFA caused simple steatosis, suggesting that the type of fatty acid is more important for the progression of NAFLD.

Citing Articles

Linoelaidic acid gavage has more severe consequences on triglycerides accumulation, inflammation and intestinal microbiota in mice than elaidic acid.

Wan L, Li T, Yao M, Zhang B, Zhang W, Zhang J Food Chem X. 2024; 22:101328.

PMID: 38576778 PMC: 10992693. DOI: 10.1016/j.fochx.2024.101328.


Allele-specific effect of various dietary fatty acids and ETS1 transcription factor on SCD1 expression.

Tibori K, Zambo V, Orosz G, Szelenyi P, Sarnyai F, Tamasi V Sci Rep. 2024; 14(1):177.

PMID: 38167845 PMC: 10761808. DOI: 10.1038/s41598-023-50700-5.


Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies.

Jia F, Hu X, Kimura T, Tanaka N Int J Mol Sci. 2021; 22(19).

PMID: 34638640 PMC: 8508674. DOI: 10.3390/ijms221910303.


A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.

Suzuki-Kemuriyama N, Abe A, Uno K, Ogawa S, Watanabe A, Sano R Lipids Health Dis. 2020; 19(1):251.

PMID: 33317575 PMC: 7737357. DOI: 10.1186/s12944-020-01423-3.


High-trans fatty acid and high-sugar diets can cause mice with non-alcoholic steatohepatitis with liver fibrosis and potential pathogenesis.

Xin X, Cai B, Chen C, Tian H, Wang X, Hu Y Nutr Metab (Lond). 2020; 17:40.

PMID: 32508961 PMC: 7249374. DOI: 10.1186/s12986-020-00462-y.


References
1.
Lim J, Mietus-Snyder M, Valente A, Schwarz J, Lustig R . The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010; 7(5):251-64. DOI: 10.1038/nrgastro.2010.41. View

2.
Asrih M, Jornayvaz F . Diets and nonalcoholic fatty liver disease: the good and the bad. Clin Nutr. 2013; 33(2):186-90. DOI: 10.1016/j.clnu.2013.11.003. View

3.
Natarajan S, Ibrahim A . Dietary trans fatty acids alter diaphragm phospholipid fatty acid composition, triacylglycerol content and glucose transport in rats. Br J Nutr. 2005; 93(6):829-33. DOI: 10.1079/BJN20051442. View

4.
Tetri L, Basaranoglu M, Brunt E, Yerian L, Neuschwander-Tetri B . Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol. 2008; 295(5):G987-95. PMC: 4059366. DOI: 10.1152/ajpgi.90272.2008. View

5.
Chen S, Zhao X, Ran L, Wan J, Wang X, Qin Y . Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig Liver Dis. 2015; 47(3):226-32. DOI: 10.1016/j.dld.2014.11.015. View